目次
第1章 方法論と範囲
1.1. 市場のセグメンテーションと範囲
1.2. 市場の定義
1.3. 情報収集
1.3.1. 購入データベース
1.3.2. GVRの内部データベース
1.3.3. 二次的性質と第三者視点
1.3.4. 一次調査
1.4. 情報分析
1.4.1. データ分析モデル
1.5. 市場情報とデータ可視化
1.6. データの検証と公開
第2章 エグゼクティブサマリー
2.1. 市場の見通し
2.2. 自然の見通し
2.3. 種類の見通し
2.4. 形態の見通し
2.5. 流通チャネルの見通し
2.6. 地域の見通し
2.7. 競合の見通し
第3章 アダプトゲン市場の変数、トレンド、および展望
3.1. 市場の系譜の見通し
3.2. 業界のバリューチェーン分析
3.2.1. 販売/小売チャネル分析
3.2.2. 利益率分析
3.3. 市場力学
3.3.1. 市場推進要因分析
3.3.2. 市場抑制要因分析
3.3.3. 業界の課題
3.3.4. 業界の機会
3.4. 業界分析 – ポーターのファイブフォース分析
3.5. 市場参入戦略
第4章 アダプトゲン市場:性質分析および予測
4.1. アダプトゲン市場:性質別:主な要点
4.2. 性質別市場動向分析および市場シェア、2023年および2030年
4.3. 性質別市場予測および予測、2018年~2030年(百万米ドル
4.3.1. 有機
4.3.1.1. 市場予測と予測、2018年~2030年(百万米ドル)
4.3.2. 合成
4.3.2.1. 市場予測と予測、2018年~2030年(百万米ドル)
第5章 アダプトゲン市場:タイプ別分析と予測
5.1. アダプトゲン市場:タイプ別:主な要点
5.2. タイプ別市場分析および市場シェア、2023年および2030年
5.3. タイプ別市場予測および予測、2018年~2030年(百万米ドル)
5.3.1. アシュワガンダ
5.3.1.1. 市場予測および予測、2018年~2030年(百万米ドル)
5.3.2. 高麗人参
5.3.2.1. 市場予測と予測、2018年~2030年(百万米ドル)
5.3.3. ツルシ
5.3.3.1. 市場予測と予測、2018年~2030年(百万米ドル)
5.3.4. 冬虫夏草
5.3.4.1. 市場規模の推計および予測、2018年~2030年(百万米ドル)
5.3.5. その他
5.3.5.1. 市場規模の推計および予測、2018年~2030年(百万米ドル)
第6章 アダプトゲン市場:形態別推計およびトレンド分析
6.1. アダプトゲン市場:形態別:主な要点
6.2. 形態別市場分析および市場シェア、2023年および2030年
6.3. 形態別市場予測、2018年~2030年(単位:百万米ドル)
6.3.1. カプセル
6.3.1.1. 市場予測および予測、2018年~2030年(単位:百万米ドル)
6.3.2. パウダー
6.3.2.1. 市場予測と予測、2018年~2030年(百万米ドル)
6.3.3. 茶類および飲料
6.3.3.1. 市場予測と予測、2018年~2030年(百万米ドル)
6.3.4. その他
6.3.4.1. 市場予測と予測、2018年~2030年(百万米ドル)
第7章 アダプトゲン市場:流通チャネル予測と傾向分析
7.1. アダプトゲン市場:流通チャネル別:主な要点
7.2. 流通チャネルの動きの分析と市場シェア、2023年と2030年
7.3. 流通チャネル別市場予測と予測、2018年~2030年(百万米ドル)
7.3.1. B2B
7.3.1.1. 市場予測と予測、2018年~2030年(百万米ドル)
7.3.2. B2C
7.3.2.1. 市場予測と予測、2018年~2030年(百万米ドル)
7.3.2.2. スーパーマーケットおよびハイパーマーケット
7.3.2.2.1. 市場予測と予測、2018年~2030年(百万米ドル)
7.3.2.3. コンビニエンスストア
7.3.2.3.1. 市場予測と予測、2018年~2030年(百万米ドル)
7.3.2.4. オンライン
7.3.2.4.1. 市場予測と予測、2018年~2030年(百万米ドル)
7.3.2.5. その他
7.3.2.5.1. 市場規模の推計および予測、2018年~2030年(百万米ドル)
第8章 アダプトゲン市場:地域別予測およびトレンド分析
8.1. アダプトゲン市場:地域別展望
8.2. 地域別市場動向分析および市場シェア、2023年および2030年
8.3. 地域別・国別市場予測、2018年~2030年(単位:百万米ドル)
8.3.1. 北米
8.3.1.1. 市場予測と予測、2018年~2030年(単位:百万米ドル)
8.3.1.2. 米国
8.3.1.2.1. 主要国の動向
8.3.1.2.2. 市場予測と予測、2018年~2030年(百万米ドル)
8.3.1.3. カナダ
8.3.1.3.1. 主要国の動向
8.3.1.3.2. 市場予測と予測、2018年~2030年(百万米ドル)
8.3.1.4. メキシコ
8.3.1.4.1. 主要国の動向
8.3.1.4.2. 市場予測と見通し、2018年~2030年(百万米ドル)
8.3.2. ヨーロッパ
8.3.2.1. 市場予測と見通し、2018年~2030年(百万米ドル)
8.3.2.2. 英国
8.3.2.2.1. 主要国の動向
8.3.2.2.2. 市場予測と予測、2018年~2030年(百万米ドル)
8.3.2.3. ドイツ
8.3.2.3.1. 主要国の動向
8.3.2.3.2. 市場予測と予測、2018年~2030年(百万米ドル)
8.3.2.4. フランス
8.3.2.4.1. 主要国の動向
8.3.2.4.2. 市場予測と見通し、2018年~2030年(百万米ドル)
8.3.2.5. スペイン
8.3.2.5.1. 主要国の動向
8.3.2.5.2. 市場予測と予測、2018年~2030年(百万米ドル)
8.3.2.6. イタリア
8.3.2.6.1. 主要国の動向
8.3.2.6.2. 市場予測と予測、2018年~2030年(百万米ドル)
8.3.3. アジア太平洋
8.3.3.1. 市場予測と予測、2018年~2030年(百万米ドル)
8.3.3.2. 中国
8.3.3.2.1. 主要国の動向
8.3.3.2.2. 市場予測と予測、2018年~2030年(百万米ドル)
8.3.3.3. 日本
8.3.3.3.1. 主要国の動向
8.3.3.3.2. 市場予測と予測、2018年~2030年(百万米ドル)
8.3.3.4. インド
8.3.3.4.1. 主要国の動向
8.3.3.4.2. 市場予測と予測、2018年~2030年(百万米ドル)
8.3.3.5. 韓国
8.3.3.5.1. 主要国の動向
8.3.3.5.2. 市場予測と見通し、2018年~2030年(百万米ドル
8.3.3.6. オーストラリアおよびニュージーランド
8.3.3.6.1. 主要国の動向
8.3.3.6.2. 市場予測と予測、2018年~2030年(百万米ドル)
8.3.4. 中南米
8.3.4.1. 市場予測と予測、2018年~2030年(百万米ドル)
8.3.4.2. ブラジル
8.3.4.2.1. 主要国の動向
8.3.4.2.2. 市場予測と予測、2018年~2030年(百万米ドル)
8.3.5. 中東およびアフリカ
8.3.5.1. 市場予測と予測、2018年~2030年(百万米ドル)
8.3.5.2. アラブ首長国連邦
8.3.5.2.1. 主要国の動向
8.3.5.2.2. 市場予測と予測、2018年~2030年(百万米ドル)
第9章 競合分析
9.1. 主要市場参加者の最近の動向と影響分析
9.2. 企業分類
9.3. 参加者の概要
9.4. 財務実績
9.5. 製品ベンチマーキング
9.6. 企業市場シェア分析、2023年(%)
9.7. 企業ヒートマップ分析
9.8. 戦略マッピング
9.9. 企業プロフィール
Nutraceutical International Corporation
Organic India Private Limited
Himalaya Global Holdings Ltd.
Rejuvenating Herbs & Nutrition, Inc. (REBBL)
Embria Health Sciences, LLC
Natreon, Inc.
Amax NutraSource, Inc.
PLT Health Solutions, Inc.
Xiamen Kingdomway Group Company
KSM-66 Ashwagandha (Ixoreal Biomed Inc.)
The global adaptogens market size is expected to reach USD 16.32 billion by 2030, growing at a CAGR of 7.0% from 2024 to 2030, according to a new report by Grand View Research, Inc. As people become more health-conscious, they are seeking holistic solutions that can help manage stress, anxiety, and fatigue. Adaptogens, which are natural substances derived from plants and mushrooms that help the body adapt to stress, have gained popularity for their potential benefits in enhancing mental clarity and overall vitality. This shift towards natural health solutions aligns with a broader trend of consumers prioritizing wellness and preventive care.
Technological advancements in the extraction and formulation of adaptogenic ingredients have also played a crucial role in market expansion. Improved methods allow for higher potency and better bioavailability of these compounds, making them more appealing to consumers. As research continues to unveil the diverse benefits of adaptogenic herbs, such as ashwagandha, Rhodiola, and ginseng, consumer awareness and acceptance are expected to grow, further driving market demand.
The integration of adaptogens into various product categories is another significant trend fueling market growth. Adaptogens are increasingly being incorporated into functional foods, beverages, dietary supplements, and even cosmetics. This versatility allows consumers to easily incorporate these beneficial ingredients into their daily routines, whether through smoothies, teas, or skincare products. The trend towards functional foods—products that offer health benefits beyond basic nutrition—has particularly boosted the demand for adaptogen-infused items.
Additionally, the rise of e-commerce has made adaptogen products more accessible to consumers. Online shopping platforms provide a convenient way for individuals to explore a wide range of adaptogenic products from various brands, facilitating informed purchasing decisions through product reviews and detailed information. The COVID-19 pandemic has further accelerated this shift towards online retail, as consumers seek convenient options for their health needs.
Adaptogens Market Report Highlights
• Based on nature, synthetic adaptogens accounted for a share of 76.4% in 2023.The pharmaceutical and functional food industries are increasingly incorporating synthetic adaptogens due to their predictable effects, safety profile, and the ease of integration into a wide range of products. This trend is contributing to the growing use of synthetic adaptogens in supplements, nutraceuticals, and functional beverages aimed at boosting mental and physical well-being.
• Based on type, Tulsi is expected to grow at a CAGR of 7.1% from 2024 to 2030.With growing awareness of health and wellness, consumers are increasingly looking for natural solutions to support their physical and mental well-being. Tulsi is recognized for its anti-inflammatory, antioxidant, and stress-relief properties, making it a popular choice for those seeking to enhance their overall health.
• Based on form, teas & beverages is expected to grow at a CAGR of 7.1% from 2024 to 2030.The beverage market is seeing significant innovation, with a wide range of flavors and combinations available. Many brands are creatively blending adaptogens with various herbs, spices, and natural flavors, making these drinks enjoyable and attractive to a broader audience. This variety encourages consumers to try adaptogenic beverages as part of their daily routine.
• Based on distribution channel, B2B accounted for a market share of 79.7% in 2023. The rise of niche markets, such as vegan, gluten-free, and keto-friendly products, is driving demand for adaptogens. B2B suppliers can cater to these specialized markets by providing adaptogenic ingredients that meet specific dietary requirements and health claims, facilitating the growth of diverse product lines within the health and wellness industry.
• Based on region, Asia Pacific is expected to grow at a CAGR of 7.8% from 2024 to 2030. In Asia Pacific, adaptogens such as ginseng and ashwagandha have long been used in traditional medicine systems like Ayurveda and Traditional Chinese Medicine (TCM). The growing interest in returning to natural, time-tested remedies is boosting the demand for adaptogens in both modern wellness products and traditional health practices.
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Natures & Third-Party Perspectives
1.3.4. Primary Research
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Information & Data Visualization
1.6. Data Validation & Publishing
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Nature Outlook
2.3. Type Outlook
2.4. Form Outlook
2.5. Distribution Channel Outlook
2.6. Regional Outlook
2.7. Competitive Insights
Chapter 3. Adaptogens Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.2. Industry Value Chain Analysis
3.2.1. Sales/Retail Channel Analysis
3.2.2. Profit Margin Analysis
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.3.3. Industry Challenges
3.3.4. Industry Opportunities
3.4. Industry Analysis - Porter’s Five Force Analysis
3.5. Market Entry Strategies
Chapter 4. Adaptogens Market: Nature Analysis & Estimates
4.1. Adaptogens Market, by Nature: Key Takeaways
4.2. Nature Movement Analysis & Market Share, 2023 & 2030
4.3. Market Estimates & Forecasts, by Nature, 2018 - 2030 (USD Million)
4.3.1. Organic
4.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
4.3.2. Synthetic
4.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 5. Adaptogens Market: Type Analysis & Estimates
5.1. Adaptogens Market, by Type: Key Takeaways
5.2. Type Movement Analysis & Market Share, 2023 & 2030
5.3. Market Estimates & Forecasts, by Type, 2018 - 2030 (USD Million)
5.3.1. Ashwagandha
5.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.3.2. Ginseng
5.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.3.3. Tulsi
5.3.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.3.4. Cordyceps
5.3.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.3.5. Others
5.3.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 6. Adaptogens Market: Form Estimates & Trend Analysis
6.1. Adaptogens Market, by Form: Key Takeaways
6.2. Form Movement Analysis & Market Share, 2023 & 2030
6.3. Market Estimates & Forecasts, by Form, 2018 - 2030 (USD Million)
6.3.1. Capsules
6.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.3.2. Powder
6.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.3.3. Teas & Beverages
6.3.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.3.4. Others
6.3.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 7. Adaptogens Market: Distribution Channel Estimates & Trend Analysis
7.1. Adaptogens Market, by Distribution Channel: Key Takeaways
7.2. Distribution Channel Movement Analysis & Market Share, 2023 & 2030
7.3. Market Estimates & Forecasts, by Distribution Channel, 2018 - 2030 (USD Million)
7.3.1. B2B
7.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.3.2. B2C
7.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.3.2.2. Supermarkets & Hypermarkets
7.3.2.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.3.2.3. Convenience Stores
7.3.2.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.3.2.4. Online
7.3.2.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.3.2.5. Others
7.3.2.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 8. Adaptogens Market: Regional Estimates & Trend Analysis
8.1. Adaptogens Market: Regional Outlook
8.2. Regional Movement Analysis & Market Share, 2023 & 2030
8.3. Market Estimates & Forecasts, by Region & Country, 2018 - 2030 (USD Million)
8.3.1. North America
8.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
8.3.1.2. U.S.
8.3.1.2.1. Key country dynamics
8.3.1.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
8.3.1.3. Canada
8.3.1.3.1. Key country dynamics
8.3.1.3.2. Market estimates and forecast, 2018 - 2030 (USD Million)
8.3.1.4. Mexico
8.3.1.4.1. Key country dynamics
8.3.1.4.2. Market estimates and forecast, 2018 - 2030 (USD Million)
8.3.2. Europe
8.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
8.3.2.2. UK
8.3.2.2.1. Key country dynamics
8.3.2.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
8.3.2.3. Germany
8.3.2.3.1. Key country dynamics
8.3.2.3.2. Market estimates and forecast, 2018 - 2030 (USD Million)
8.3.2.4. France
8.3.2.4.1. Key country dynamics
8.3.2.4.2. Market estimates and forecast, 2018 - 2030 (USD Million)
8.3.2.5. Spain
8.3.2.5.1. Key country dynamics
8.3.2.5.2. Market estimates and forecast, 2018 - 2030 (USD Million)
8.3.2.6. Italy
8.3.2.6.1. Key country dynamics
8.3.2.6.2. Market estimates and forecast, 2018 - 2030 (USD Million)
8.3.3. Asia Pacific
8.3.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
8.3.3.2. China
8.3.3.2.1. Key country dynamics
8.3.3.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
8.3.3.3. Japan
8.3.3.3.1. Key country dynamics
8.3.3.3.2. Market estimates and forecast, 2018 - 2030 (USD Million)
8.3.3.4. India
8.3.3.4.1. Key country dynamics
8.3.3.4.2. Market estimates and forecast, 2018 - 2030 (USD Million)
8.3.3.5. South Korea
8.3.3.5.1. Key country dynamics
8.3.3.5.2. Market estimates and forecast, 2018 - 2030 (USD Million)
8.3.3.6. Australia & New Zealand
8.3.3.6.1. Key country dynamics
8.3.3.6.2. Market estimates and forecast, 2018 - 2030 (USD Million)
8.3.4. Central & South America
8.3.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
8.3.4.2. Brazil
8.3.4.2.1. Key country dynamics
8.3.4.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
8.3.5. Middle East & Africa
8.3.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
8.3.5.2. UAE
8.3.5.2.1. Key country dynamics
8.3.5.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 9. Competitive Analysis
9.1. Recent developments & impact analysis, by key market participants
9.2. Company Categorization
9.3. Participant’s Overview
9.4. Financial Performance
9.5. Product Benchmarking
9.6. Company Market Share Analysis, 2023 (%)
9.7. Company Heat Map Analysis
9.8. Strategy Mapping
9.9. Company Profiles
9.10. Nutraceutical International Corporation
9.10.1. Company Overview
9.10.2. Financial Performance
9.10.3. Product Benchmarking
9.10.4. Strategic Initiatives
9.11. Organic India Private Limited
9.11.1. Company Overview
9.11.2. Financial Performance
9.11.3. Product Benchmarking
9.11.4. Strategic Initiatives
9.12. Himalaya Global Holdings Ltd.
9.12.1. Company Overview
9.12.2. Financial Performance
9.12.3. Product Benchmarking
9.12.4. Strategic Initiatives
9.13. Rejuvenating Herbs & Nutrition, Inc. (REBBL)
9.13.1. Company Overview
9.13.2. Financial Pertypeance
9.13.3. Product Benchmarking
9.13.4. Strategic Initiatives
9.14. Embria Health Sciences, LLC
9.14.1. Company Overview
9.14.2. Financial Performance
9.14.3. Product Benchmarking
9.14.4. Strategic Initiatives
9.15. Natreon, Inc.
9.15.1. Company Overview
9.15.2. Financial Performance
9.15.3. Product Benchmarking
9.15.4. Strategic Initiatives
9.16. Amax NutraSource, Inc.
9.16.1. Company Overview
9.16.2. Financial Performance
9.16.3. Product Benchmarking
9.16.4. Strategic Initiatives
9.17. PLT Health Solutions, Inc.
9.17.1. Company Overview
9.17.2. Financial Performance
9.17.3. Product Benchmarking
9.17.4. Strategic Initiatives
9.18. Xiamen Kingdomway Group Company
9.18.1. Company Overview
9.18.2. Financial Performance
9.18.3. Product Benchmarking
9.18.4. Strategic Initiatives
9.19. KSM-66 Ashwagandha (Ixoreal Biomed Inc.)
9.19.1. Company Overview
9.19.2. Financial Performance
9.19.3. Product Benchmarking
9.19.4. Strategic Initiatives
*** アダプトゲンの世界市場に関するよくある質問(FAQ) ***
・アダプトゲンの世界市場規模は?
→Grand View Research社は2024年のアダプトゲンの世界市場規模をXX米ドルと推定しています。
・アダプトゲンの世界市場予測は?
→Grand View Research社は2030年のアダプトゲンの世界市場規模を163.2億米ドルと予測しています。
・アダプトゲン市場の成長率は?
→Grand View Research社はアダプトゲンの世界市場が2024年~2030年に年平均7.0%成長すると展望しています。
・世界のアダプトゲン市場における主要プレイヤーは?
→「Nutraceutical International Corporation, Organic India Private Limited, Himalaya Global Holdings Ltd., Rejuvenating Herbs & Nutrition, Inc. (REBBL), Embria Health Sciences, LLC, Natreon, Inc., Amax NutraSource, Inc., PLT Health Solutions, Inc., Xiamen Kingdomway Group Company, KSM-66 Ashwagandha (Ixoreal Biomed Inc.)など ...」をアダプトゲン市場のグローバル主要プレイヤーとして判断しています。
※上記FAQの市場規模、市場予測、成長率、主要企業に関する情報は本レポートの概要を作成した時点での情報であり、最終レポートの情報と少し異なる場合があります。
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/